BR0001559A - Vacina para a prevenção da colonização de campylobacter em animais, proteìna antigênica de campylobacter, uso de uma proteìna antigênica, vacina para a prevenção da colonização de campylobacter jejuni em galináceos, uso de anticorpos contra uma cepa de campylobacter sem flagelos, ou contra a proteìna antigênica, e, processo para a preparação de uma vacina - Google Patents
Vacina para a prevenção da colonização de campylobacter em animais, proteìna antigênica de campylobacter, uso de uma proteìna antigênica, vacina para a prevenção da colonização de campylobacter jejuni em galináceos, uso de anticorpos contra uma cepa de campylobacter sem flagelos, ou contra a proteìna antigênica, e, processo para a preparação de uma vacinaInfo
- Publication number
- BR0001559A BR0001559A BR0001559-8A BR0001559A BR0001559A BR 0001559 A BR0001559 A BR 0001559A BR 0001559 A BR0001559 A BR 0001559A BR 0001559 A BR0001559 A BR 0001559A
- Authority
- BR
- Brazil
- Prior art keywords
- campylobacter
- vaccine
- antigenic protein
- colonization
- prevention
- Prior art date
Links
- 241000589876 Campylobacter Species 0.000 title abstract 12
- 229960005486 vaccine Drugs 0.000 title abstract 11
- 102000004169 proteins and genes Human genes 0.000 title abstract 10
- 108090000623 proteins and genes Proteins 0.000 title abstract 10
- 230000000890 antigenic effect Effects 0.000 title abstract 7
- 230000002265 prevention Effects 0.000 title abstract 5
- 241000589875 Campylobacter jejuni Species 0.000 title abstract 3
- 241001465754 Metazoa Species 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 241000287828 Gallus gallus Species 0.000 title 1
- 235000013330 chicken meat Nutrition 0.000 title 1
- 238000011534 incubation Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/121—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/826—Bacterial vaccine for avian species, e.g. poultry or other birds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"VACINA PARA A PREVENçãO DA COLONIZAçãO DE CAMPYLOBACTER EM ANIMAIS, PROTEìNA ANTIGêNICA DE CAMPYLOBACTER, USO DE UMA PROTEìNA ANTIGêNICA, VACINA PARA A PREVENçãO DA COLONIZAçãO DE CAMPYLOBACTER JEJUNI EM GALINáCEOS, USO DE ANTICORPOS CONTRA UMA CEPA DE CAMPYLOBACTER SEM FLAGELOS, OU CONTRA A PROTEìNA ANTIGêNICA, E, PROCESSO PARA A PREPARAçãO DE UMA VACINA" A presente invenção refere-se a vacinas compreendendo anti-soro desenvolvido contra uma cepa de Campylobacter sem flagelos para a prevenção da colonização de Campylobacter em animais. A invenção também se refere a proteínas de Campylobacter antigênicas visíveis em um Wedtern blot de proteína de Campylobacter jejuni após a incubação do referido Wedtern blot com anticorpos contra um mutante sem flagelos de Campylobacter jejuni e não visível após a incubação do referido blot com anticorpos contra Campylobacter jejuni de tipo selvagem, e a seu uso em vacinas e a sua manufatura. A invenção ainda se refere a vacinas que compreendem essas proteínas e anticorpos contra essas proteínas. A invenção ainda se refere ao uso dessas proteínas de Campylobacter, e ao anti-soro e a anticorpos desenvolvidos contra antígenos de Campylobacter para a preparação de vacinas. Finalmente, a invenção refere-se a processos para a preparação dessas vacinas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99201086 | 1999-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0001559A true BR0001559A (pt) | 2001-08-21 |
Family
ID=8240072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0001559-8A BR0001559A (pt) | 1999-04-09 | 2000-04-07 | Vacina para a prevenção da colonização de campylobacter em animais, proteìna antigênica de campylobacter, uso de uma proteìna antigênica, vacina para a prevenção da colonização de campylobacter jejuni em galináceos, uso de anticorpos contra uma cepa de campylobacter sem flagelos, ou contra a proteìna antigênica, e, processo para a preparação de uma vacina |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6787137B1 (pt) |
| JP (1) | JP2000351735A (pt) |
| KR (1) | KR20010014710A (pt) |
| CN (1) | CN1170594C (pt) |
| AU (1) | AU775752B2 (pt) |
| BR (1) | BR0001559A (pt) |
| CA (1) | CA2303722A1 (pt) |
| HU (1) | HUP0001423A3 (pt) |
| MX (1) | MXPA00003427A (pt) |
| PL (1) | PL339513A1 (pt) |
| TW (1) | TW200418874A (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ546601A (en) | 2003-09-19 | 2010-07-30 | Epitopix Llc | Compositions comprising at least six isolated metal regulated polypeptides obtainable from campylobacter spp |
| PL1694697T3 (pl) * | 2003-11-21 | 2011-05-31 | Ace Biosciences As | Zlokalizowane na powierzchni polipeptydy campylobacter jejuni |
| EP2161035B1 (en) * | 2007-05-28 | 2019-08-21 | Daiichi Sankyo Company, Limited | Bordetella parapertussis-containing whole-cell vaccine composition |
| PL2579901T3 (pl) * | 2010-06-09 | 2020-02-28 | The Board Of Trustees Of The University Of Arkansas | Szczepionka i sposoby ograniczania infekcji campylobacter |
| WO2017199094A1 (en) | 2016-05-20 | 2017-11-23 | Novobind Livestock Therapeutics Inc. | Antibodies against microorganisms and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4748018A (en) * | 1984-02-07 | 1988-05-31 | Stolle Research & Development Corp. | Method of passive immunization of mammals using avian antibody |
| US5200344A (en) * | 1990-11-13 | 1993-04-06 | Blaser Martin J | Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens |
| JPH09502604A (ja) * | 1993-08-27 | 1997-03-18 | エンテリック リサーチ ラボラトリーズ インコーポレイテッド | Ｃａｍｐｙｌｏｂａｃｔｅｒｊｅｊｕｎｉ抗原、並びにそれらの製造及び利用 |
| US5681736A (en) * | 1994-10-05 | 1997-10-28 | Antex Biologics, Inc. | Methods for producing enhanced antigenic shigella bacteria and vaccines comprising same |
| US5827654A (en) | 1995-05-08 | 1998-10-27 | University Of Toronto | Basal body rod protein genes of campylobacter |
| DE19548221C1 (de) * | 1995-12-22 | 1997-05-15 | Biotest Pharma Gmbh | Orale Anwendung von Immunglobulin-Präparationen zur Behandlung und Prophylaxe chronischer Schmerzzustände |
| CA2227932A1 (en) * | 1997-04-08 | 1998-10-08 | Voon Loong Chan | Gene encoding invasion protein of campylobacter jejuni |
| US6156546A (en) * | 1997-05-16 | 2000-12-05 | Washington State University Research Foundation | Identification and molecular cloning of a gene encoding a fibronectin binding protein (CadF) from Campylobacter coli and Campylobacter jejuni |
| EP1043029A1 (en) * | 1999-04-09 | 2000-10-11 | Akzo Nobel N.V. | Campylobacter vaccine |
-
2000
- 2000-03-28 JP JP2000088054A patent/JP2000351735A/ja not_active Withdrawn
- 2000-04-05 AU AU26406/00A patent/AU775752B2/en not_active Ceased
- 2000-04-05 CA CA002303722A patent/CA2303722A1/en not_active Abandoned
- 2000-04-07 US US09/544,683 patent/US6787137B1/en not_active Expired - Fee Related
- 2000-04-07 MX MXPA00003427A patent/MXPA00003427A/es unknown
- 2000-04-07 BR BR0001559-8A patent/BR0001559A/pt not_active IP Right Cessation
- 2000-04-07 HU HU0001423A patent/HUP0001423A3/hu unknown
- 2000-04-07 CN CNB001049828A patent/CN1170594C/zh not_active Expired - Fee Related
- 2000-04-07 PL PL00339513A patent/PL339513A1/xx not_active Application Discontinuation
- 2000-04-08 KR KR1020000018491A patent/KR20010014710A/ko not_active Application Discontinuation
- 2000-04-29 TW TW093111042A patent/TW200418874A/zh unknown
-
2002
- 2002-07-10 US US10/192,419 patent/US6790446B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| TW200418874A (en) | 2004-10-01 |
| HUP0001423A3 (en) | 2005-05-30 |
| HU0001423D0 (en) | 2000-06-28 |
| US6787137B1 (en) | 2004-09-07 |
| CN1170594C (zh) | 2004-10-13 |
| CN1270061A (zh) | 2000-10-18 |
| CA2303722A1 (en) | 2000-10-09 |
| PL339513A1 (en) | 2000-10-23 |
| KR20010014710A (ko) | 2001-02-26 |
| MXPA00003427A (es) | 2004-10-28 |
| US20030072766A1 (en) | 2003-04-17 |
| JP2000351735A (ja) | 2000-12-19 |
| AU775752B2 (en) | 2004-08-12 |
| HUP0001423A2 (en) | 2002-06-29 |
| US6790446B2 (en) | 2004-09-14 |
| AU2640600A (en) | 2000-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Knox et al. | Vaccination against gastrointestinal nematode parasites of ruminants using gut-expressed antigens | |
| Martin et al. | Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis | |
| TWI311057B (en) | C. perfringens alpha toxoid vaccine | |
| Silverstein et al. | Fetal Response to Antigenic Stimulus: III. γ-Globulin Production in Normal and Stimulated Fetal Lambs | |
| WO1999051266A3 (en) | Derivatives of pneumococcal choline binding proteins for vaccines | |
| BR0208301A (pt) | Vacinas de ácido nucléico para prevenção de infecção por flavivìrus | |
| BR9815255A (pt) | Toxina de botulismo modificada, vacina oralcontra o botulismo, vacina oral contra umantìgeno selecionado e método para ministraroralmente um agente terapêutico a um animal | |
| Cole et al. | Interactions of mycoplasmas and their products with lymphoid cells in vitro | |
| JPH06505024A (ja) | 抗原を用いるＣａｍｐｙｌｏｂａｃｔｅｒ ｊｅｊｕｎｉ又はｃｏｌｉ感染の診断試験 | |
| WO2019193078A1 (en) | A vaccine for protection against streptococcus suis | |
| Smith et al. | Cross‐protection studies with gut membrane glycoprotein antigens from Haemonchus contortus and Teladorsagia circumcincta | |
| HUP9801223A2 (hu) | Eljárás specifikus antigénekre adott antitest válasz fokozására interleukin-10-zel | |
| US5807551A (en) | Method to provide artificial passive immunity in birds | |
| Hastings et al. | Detection of antibodies induced in rainbow trout by different Aeromonas salmonicida vaccine preparations | |
| BR0001559A (pt) | Vacina para a prevenção da colonização de campylobacter em animais, proteìna antigênica de campylobacter, uso de uma proteìna antigênica, vacina para a prevenção da colonização de campylobacter jejuni em galináceos, uso de anticorpos contra uma cepa de campylobacter sem flagelos, ou contra a proteìna antigênica, e, processo para a preparação de uma vacina | |
| Tyler et al. | Antigenic homology among gram-negative organisms isolated from cattle with clinical mastitis | |
| BR0109928A (pt) | Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal | |
| BR9916549A (pt) | Composição farmacêutica, vacina, proteìna, e, método para a prevenção ou tratamento de leishmaniose em um humano ou animal | |
| Anderson et al. | Capsular antigens noncovalently or covalently associated with protein as vaccines to Haemophilus influenzae type b: comparison in two-year-old children | |
| McFerran et al. | Comparative studies with inactivated and attenuated vaccines for protection of fattening pigs | |
| AU6435596A (en) | Pasteurella haemolytica type A-1 bacterin-toxoid vaccine | |
| Morter et al. | Evaluating the efficacy of a Haemophilus somnus bacterin in a controlled field trial | |
| Shyam et al. | Protective efficacy of calcium phosphate nanoparticle adsorbed bivalent subunit vaccine of pasteurella multocida against homologous challenge in mice | |
| Menšík et al. | Development of Antibody Response to Swine Influenza Virus in Pigs: I. The Influence of Experimental Infection of Pregnant Sows on Serum Antibody Production by their Progeny during Postnatal Development | |
| Shewen | Host response to infection with HAP: Implications for vaccine development |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7O, 8O E 9O ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009. |